S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ME 23andMe Holding Company

3.17

-0.04 (-1.25%)

Dec 24 2024 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Shares were purchased in a series of private financings. new shares issued when company went public via a De Spac transaction.

Date of Notice

11/15/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Sequoia Grove UK LP

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

23andMe (NASDAQ:ME)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more 23andMe Charts.

23andMe (NASDAQ:ME)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more 23andMe Charts.

23andMe Holding Company News

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 21 November 2024 (1 month ago) • Edgar (US Regulatory)

23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation
Wednesday 20 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

23andMe Reports Second Quarter Fiscal Year 2025 Financial Results
Tuesday 12 November 2024 (1 month ago) • GlobeNewswire Inc.

23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future
Monday 11 November 2024 (1 month ago) • GlobeNewswire Inc.

CORRECTION - 23andMe to Report Q2 FY2025 Financial Results
Thursday 7 November 2024 (2 months ago) • GlobeNewswire Inc.

23andMe to Report Q2 FY2025 Financial Results
Thursday 7 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 30 October 2024 (2 months ago) • Edgar (US Regulatory)

23andMe Regains Compliance With Nasdaq Listing Requirements
Wednesday 30 October 2024 (2 months ago) • GlobeNewswire Inc.

More 23andMe Holding Company News Articles

Digital Brand Media and ... (PK)

Anavex Life Sciences

Intergrated Cannabis Sol... (PK)

Fannie Mae (QB)

Northwest Biotherapeutics (QB)

Lightwave Logic

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions